Overview

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
HIV infected people often must take anti-HIV drugs for long periods, leading to long-term drug exposure and toxicity. Interruptions in anti-HIV therapy, also known as structured treatment interruptions (STIs), may have few negative health effects and may be helpful to the overall long-term health of HIV-infected people. The purpose of this study is to determine if sequential short-term STIs of antiretroviral therapy (ART) in HIV infected individuals in a resource-constrained environment can retain the immune reconstitution benefits of continuous treatment while potentially lessening rates of toxicity associated with continuous therapy strategies and at the same time, lessen costs associated with ART.
Phase:
N/A
Details
Lead Sponsor:
The Wistar Institute
Treatments:
Lamivudine
Lopinavir
Ritonavir
Stavudine